Ventricular septal defect history and symptoms: Difference between revisions

Jump to navigation Jump to search
Priyamvada Singh (talk | contribs)
No edit summary
Priyamvada Singh (talk | contribs)
No edit summary
Line 9: Line 9:




Patients with ventricular septal defects may not have symptoms. However, if the hole is large, the baby often has symptoms related to heart failure.
{{SI}}


The most common symptoms include:
{{CMG}} and Leida Perez, M.D.


* Shortness of breath
'''Associate Editor-in-Chief:''' [[User:KeriShafer|Keri Shafer, M.D.]] [mailto:kshafer@bidmc.harvard.edu], [[Priyamvada Singh]], [[MBBS]]
* Fast breathing
* Hard breathing
* Paleness
* Failure to gain weight
* Fast heart rate
* Sweating while feeding
* Frequent respiratory infections


{{EH}}


==Sources==
==Clinical Features==
Depends on the size of the defect and the pulmonary vascular resistence (PVR). Defects in the muscular septum and subtricuspid defects frequently close or get smaller with time. Subaortic defects do not close spontaneously because the superior border is the aortic valve.
 
===Clinical Features of Small VSDs===
 
Generally, the course is benign throughout infancy and childhood.
 
===Clinical Features of Medium-Sized VSDs===
 
Common in infancy, rarely seen in adults.
 
More common in adulthood is a medium-sized left to right shunt of other causes, either a large VSD with protective infundibular stenosis, or a large VSD partially occluded by a septal leaflet of the tricuspid valve.
===Clinical Features of Large VSDs===
 
From age 1 to 12 months severe symptoms are due to LV failure secondary to a large left-to-right shunt.
 
a) tachypnea
 
b) excess sweating
 
c) fatigue with feeding
 
d) all these become progressively worse
 
e) respond well to medical therapy and the development of LVH also allows the LV to handle larger flows.
 
From 6 to 24 months, there are decreased symptoms due to a decrease in left-to-right shunting. Causes of the decreased shunt include:
 
a) may be due to spontaneous closure of the defect
 
b) there may be a progressive increase in the Pulmonary vascular resistance (PVR, the most frequent cause).
 
c) occasionally there is protective hypertrophy of the outflow tract of the RV. This increases resistance through the pulmonary
circuit and decreases the shunt to that of a moderate-sized defect. Usually this obstruction becomes severe and the patient develops
a '''tetralogy of Fallot type of syndrome'''.
 
These patients must be studied during the first year of life.
It is within the first year that these patients develop pulmonary vascular obstructive disease, and unless surgical repair is undertaken they become inoperable.
 
Because of the rise in the Puylmonary vascular resistance, the majority of these patients become fairly asymptomatic at age 12 to 24 months, but in adolescence, the pulmonary vascular resistance becomes so high that right-to-left shunting develops and the patients develop cyanosis and the "Eisenmenger's complex".
 
The definition of '''Eisenmenger's syndrome''' is officially any defect which allows free communication between the pulmonary and systemic circuits with a predominant right-to-left shunt secondary to a large rise in the PVR. Features include:
 
a) chest pain resembling angina
 
b) exertional syncope
 
c) hemoptysis
 
d) cerebral thrombosis related to the high hematocrit value
 
e) cerebral abscesses related to paradoxic emboli
 
f) death in the third decade, usually is sudden, particularly high mortality rate in pregnant women.
 
==References==
{{reflist|2}}
 
[[Category: Cardiology]]
 
{{WH}}
 
{{WS}}


http://www.nlm.nih.gov/medlineplus/ency/article/001099.htm


==References==
==References==

Revision as of 18:20, 8 July 2011

Ventricular septal defect Microchapters

Home

Patient Information

Overview

Classification

Pathophysiology

Causes

Differentiating Ventricular Septal Defect from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography

Cardiac Catheterization

Treatment

Medical Therapy

Surgery

Ventricular septal defect post-surgical prognosis

ACC/AHA Guidelines for Surgical and Catheter Intervention Follow-Up

Prevention

ACC/AHA Guidelines for Reproduction

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Ventricular septal defect history and symptoms On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Ventricular septal defect history and symptoms

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Ventricular septal defect history and symptoms

CDC on Ventricular septal defect history and symptoms

Ventricular septal defect history and symptoms in the news

Blogs on Ventricular septal defect history and symptoms

Directions to Hospitals Treating Ventricular septal defect

Risk calculators and risk factors for Ventricular septal defect history and symptoms


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]and Leida Perez, M.D.

Associate Editor-In-Chief: Keri Shafer, M.D. [2],Atif Mohammad, M.D., Priyamvada Singh, MBBS



WikiDoc Resources for Ventricular septal defect history and symptoms

Articles

Most recent articles on Ventricular septal defect history and symptoms

Most cited articles on Ventricular septal defect history and symptoms

Review articles on Ventricular septal defect history and symptoms

Articles on Ventricular septal defect history and symptoms in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Ventricular septal defect history and symptoms

Images of Ventricular septal defect history and symptoms

Photos of Ventricular septal defect history and symptoms

Podcasts & MP3s on Ventricular septal defect history and symptoms

Videos on Ventricular septal defect history and symptoms

Evidence Based Medicine

Cochrane Collaboration on Ventricular septal defect history and symptoms

Bandolier on Ventricular septal defect history and symptoms

TRIP on Ventricular septal defect history and symptoms

Clinical Trials

Ongoing Trials on Ventricular septal defect history and symptoms at Clinical Trials.gov

Trial results on Ventricular septal defect history and symptoms

Clinical Trials on Ventricular septal defect history and symptoms at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Ventricular septal defect history and symptoms

NICE Guidance on Ventricular septal defect history and symptoms

NHS PRODIGY Guidance

FDA on Ventricular septal defect history and symptoms

CDC on Ventricular septal defect history and symptoms

Books

Books on Ventricular septal defect history and symptoms

News

Ventricular septal defect history and symptoms in the news

Be alerted to news on Ventricular septal defect history and symptoms

News trends on Ventricular septal defect history and symptoms

Commentary

Blogs on Ventricular septal defect history and symptoms

Definitions

Definitions of Ventricular septal defect history and symptoms

Patient Resources / Community

Patient resources on Ventricular septal defect history and symptoms

Discussion groups on Ventricular septal defect history and symptoms

Patient Handouts on Ventricular septal defect history and symptoms

Directions to Hospitals Treating Ventricular septal defect history and symptoms

Risk calculators and risk factors for Ventricular septal defect history and symptoms

Healthcare Provider Resources

Symptoms of Ventricular septal defect history and symptoms

Causes & Risk Factors for Ventricular septal defect history and symptoms

Diagnostic studies for Ventricular septal defect history and symptoms

Treatment of Ventricular septal defect history and symptoms

Continuing Medical Education (CME)

CME Programs on Ventricular septal defect history and symptoms

International

Ventricular septal defect history and symptoms en Espanol

Ventricular septal defect history and symptoms en Francais

Business

Ventricular septal defect history and symptoms in the Marketplace

Patents on Ventricular septal defect history and symptoms

Experimental / Informatics

List of terms related to Ventricular septal defect history and symptoms

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [3] and Leida Perez, M.D.

Associate Editor-in-Chief: Keri Shafer, M.D. [4], Priyamvada Singh, MBBS

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [5] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Clinical Features

Depends on the size of the defect and the pulmonary vascular resistence (PVR). Defects in the muscular septum and subtricuspid defects frequently close or get smaller with time. Subaortic defects do not close spontaneously because the superior border is the aortic valve.

Clinical Features of Small VSDs

Generally, the course is benign throughout infancy and childhood.

Clinical Features of Medium-Sized VSDs

Common in infancy, rarely seen in adults.

More common in adulthood is a medium-sized left to right shunt of other causes, either a large VSD with protective infundibular stenosis, or a large VSD partially occluded by a septal leaflet of the tricuspid valve.

Clinical Features of Large VSDs

From age 1 to 12 months severe symptoms are due to LV failure secondary to a large left-to-right shunt.

a) tachypnea

b) excess sweating

c) fatigue with feeding

d) all these become progressively worse

e) respond well to medical therapy and the development of LVH also allows the LV to handle larger flows.

From 6 to 24 months, there are decreased symptoms due to a decrease in left-to-right shunting. Causes of the decreased shunt include:

a) may be due to spontaneous closure of the defect

b) there may be a progressive increase in the Pulmonary vascular resistance (PVR, the most frequent cause).

c) occasionally there is protective hypertrophy of the outflow tract of the RV. This increases resistance through the pulmonary circuit and decreases the shunt to that of a moderate-sized defect. Usually this obstruction becomes severe and the patient develops a tetralogy of Fallot type of syndrome.

These patients must be studied during the first year of life. It is within the first year that these patients develop pulmonary vascular obstructive disease, and unless surgical repair is undertaken they become inoperable.

Because of the rise in the Puylmonary vascular resistance, the majority of these patients become fairly asymptomatic at age 12 to 24 months, but in adolescence, the pulmonary vascular resistance becomes so high that right-to-left shunting develops and the patients develop cyanosis and the "Eisenmenger's complex".

The definition of Eisenmenger's syndrome is officially any defect which allows free communication between the pulmonary and systemic circuits with a predominant right-to-left shunt secondary to a large rise in the PVR. Features include:

a) chest pain resembling angina

b) exertional syncope

c) hemoptysis

d) cerebral thrombosis related to the high hematocrit value

e) cerebral abscesses related to paradoxic emboli

f) death in the third decade, usually is sudden, particularly high mortality rate in pregnant women.

References

Template:WH

Template:WS


References

Template:WH

Template:WS